Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Income / (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2021	$ 118,586	$ 30	$ 355,234	$ (79)	$ (236,599)
Beginning balance, shares at Dec. 31, 2021		30,074,412
Issuance of common stock , net of issuance costs	608		608
Issuance of common stock , net of issuance costs, shares		51,769
Issuance of common stock on exercise of stock options and vesting of restricted stock units	148		148
Issuance of common stock on exercise of stock options and vesting of restricted stock units, shares		490,299
Stock based compensation	16,618		16,618
Value of share Issued in connection with acquisition	16,503	$ 6	16,497
Share issuance in connection with acquisition		5,520,000
Foreign currency translation adjustments	248			248
Unrealized gain (loss) on available for sale investments	(458)			(458)
Net loss	(51,660)				(51,660)
Ending balance at Dec. 31, 2022	100,593	$ 36	389,105	(289)	(288,259)
Ending balance, shares at Dec. 31, 2022		36,136,480
Issuance of common stock on exercise of stock options and vesting of restricted stock units	167		167
Issuance of common stock on exercise of stock options and vesting of restricted stock units, shares		374,713
Restricted stock award forfeiture	(18)		(18)
Restricted stock award forfeiture, Shares		(63,293)
Stock based compensation	5,220		5,220
Value of share Issued in connection with acquisition	7,171	$ 7	7,164
Share issuance in connection with acquisition		6,525,315
Foreign currency translation adjustments	2,789			2,789
Unrealized gain (loss) on available for sale investments	547			547
Net loss	(31,385)				(31,385)
Ending balance at Dec. 31, 2023	$ 85,084	$ 43	$ 401,638	$ 3,047	$ (319,644)
Ending balance, shares at Dec. 31, 2023		42,973,215